Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Charles

Showing results (391-400 of 519) with videos related to

Pageof 52
Sort By:
Nanoscale|January 17, 2019
Towards multiplexed near-infrared cellular imaging using gold nanostar arrays with tunable fluorescence enhancementIoannis G Theodorou, Pakatip Ruenraroengsak, Daniel A Gonzalez-Carter, et al.
Molecular Cancer Therapeutics|April 8, 2010
SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2Barrie Peck, Chun-Yuan Chen, Ka-Kei Ho, et al.
Acta Oncologica (Stockholm, Sweden)|September 18, 2014
A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancerThomas P Kole, R Charles Nichols, Song Lei, et al.
Breast Cancer Research and Treatment|January 26, 2019
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIESZsolt Szijgyarto, Koen D Flach, Mark Opdam, et al.
Nature Communications|September 4, 2019
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapySung Pil Hong, Thalia E Chan, Ylenia Lombardo, et al.
Cancer Investigation|March 7, 2019
Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate CancerR Charles Nichols, Christopher G Morris, Curtis Bryant, et al.
Clinical Lung Cancer|July 6, 2011
Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric studyR Charles Nichols, Soon N Huh, Randal H Henderson, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 18, 2024
Hospital-Acquired Complications in Critically Ill Children and PICU Length of Stay, Duration of Respiratory Support, and Economics: Propensity Score Matching in a Single-Center Cohort, 2015-2020Jessica A Schults, Lisa Hall, Karina R Charles, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 6, 2025
Hospital-Acquired Complications in Critically Ill Children and PICU Length of Stay, Duration of Respiratory Support, and Economics: Propensity Score Matching in a Single-Center Cohort, 2015-2020Jessica A Schults, Lisa Hall, Karina R Charles, et al.
Transplantation|November 20, 2002
Inhibitors of ADAMTS13: a potential factor in the cause of thrombotic microangiopathy in a renal allograft recipientPhuong-Thu T Pham, Gabriel M Danovitch, Alan H Wilkinson, et al.
Pageof 52

Showing results (391-400 of 519) with videos related to

Sort By:
Pageof 52
Nanoscale|January 17, 2019
Towards multiplexed near-infrared cellular imaging using gold nanostar arrays with tunable fluorescence enhancementIoannis G Theodorou, Pakatip Ruenraroengsak, Daniel A Gonzalez-Carter, et al.
Molecular Cancer Therapeutics|April 8, 2010
SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2Barrie Peck, Chun-Yuan Chen, Ka-Kei Ho, et al.
Acta Oncologica (Stockholm, Sweden)|September 18, 2014
A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancerThomas P Kole, R Charles Nichols, Song Lei, et al.
Breast Cancer Research and Treatment|January 26, 2019
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIESZsolt Szijgyarto, Koen D Flach, Mark Opdam, et al.
Nature Communications|September 4, 2019
Single-cell transcriptomics reveals multi-step adaptations to endocrine therapySung Pil Hong, Thalia E Chan, Ylenia Lombardo, et al.
Cancer Investigation|March 7, 2019
Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate CancerR Charles Nichols, Christopher G Morris, Curtis Bryant, et al.
Clinical Lung Cancer|July 6, 2011
Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric studyR Charles Nichols, Soon N Huh, Randal H Henderson, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|December 18, 2024
Hospital-Acquired Complications in Critically Ill Children and PICU Length of Stay, Duration of Respiratory Support, and Economics: Propensity Score Matching in a Single-Center Cohort, 2015-2020Jessica A Schults, Lisa Hall, Karina R Charles, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|March 6, 2025
Hospital-Acquired Complications in Critically Ill Children and PICU Length of Stay, Duration of Respiratory Support, and Economics: Propensity Score Matching in a Single-Center Cohort, 2015-2020Jessica A Schults, Lisa Hall, Karina R Charles, et al.
Transplantation|November 20, 2002
Inhibitors of ADAMTS13: a potential factor in the cause of thrombotic microangiopathy in a renal allograft recipientPhuong-Thu T Pham, Gabriel M Danovitch, Alan H Wilkinson, et al.
Pageof 52